GNI Group Ltd. (TYO:2160)
2,984.00
-16.00 (-0.53%)
May 12, 2026, 3:30 PM JST
GNI Group Market Cap
GNI Group has a market cap or net worth of 166.37 billion as of May 12, 2026. Its market cap has increased by 80.58% in one year.
Market Cap
166.37B
Enterprise Value
152.16B
Revenue
26.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,984.00
Market Cap Chart
Since August 31, 2007, GNI Group's market cap has increased from 5.24B to 166.37B, an increase of 3,077.56%. That is a compound annual growth rate of 20.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 167.26B | 24.59% |
| Dec 30, 2025 | 134.25B | -21.38% |
| Dec 30, 2024 | 170.75B | 21.35% |
| Dec 29, 2023 | 140.72B | 112.73% |
| Dec 30, 2022 | 66.15B | -5.89% |
| Dec 30, 2021 | 70.29B | -10.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 176.22B |
| PeptiDream | 148.08B |
| Takara Bio | 137.51B |
| Nxera Pharma | 107.05B |
| Oncolys BioPharma | 85.45B |
| Cuorips | 52.44B |
| Healios K.K. | 46.44B |
| Japan Tissue Engineering | 23.88B |